CAPREGEN NUTRACEUTICALS LIMITED

Active London

Activities of other holding companies n.e.c.

0 employees website.com
Activities of other holding companies n.e.c.
C

CAPREGEN NUTRACEUTICALS LIMITED

Activities of other holding companies n.e.c.

Founded 11 Sept 2008 Active London, United Kingdom 0 employees website.com
Activities of other holding companies n.e.c.
Accounts Submitted 10 Jul 2025 Next due 30 Sept 2026 4 months remaining
Confirmation Submitted 1 Aug 2025 Next due 15 Aug 2026 3 months remaining
Net assets £0 £24K 2024 year on year
Total assets £0 £100 2024 year on year
Total Liabilities £0 £24K 2024 year on year
Charges 3
3 satisfied

Contact & Details

Contact

Registered Address

5 Howick Place London SW1P 1WG United Kingdom

Full company profile for CAPREGEN NUTRACEUTICALS LIMITED (06695546), an active company based in London, United Kingdom. Incorporated 11 Sept 2008. Activities of other holding companies n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

N/A

Net Assets

N/A

Increased by £23.63k (+100%)

Total Liabilities

N/A

Decreased by £23.73k (-100%)

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Decreased by 23734 (-100%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 1 Shares £22k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
24 Oct 20241£22k£22k

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (2)

Tarsus Group Limited
100.0%
101
Capregen Biosciences Limited (dissolved 13/05/2025)
0.0%
0

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Tarsus Group Limited

United Kingdom

Active
Notified 24 Oct 2024
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Capregen Biosciences Limited

Ceased 24 Oct 2024

Ceased

Group Structure

Group Structure

INFORMA PLC united kingdom
TARSUS GROUP LIMITED united kingdom
CAPREGEN NUTRACEUTICALS LIMITED Current Company

Charges

Charges

3 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
8 Jan 2026OfficersChange to director Sinead Catherine Davies on 8 Jan 2026
1 Aug 2025Confirmation StatementConfirmation statement made on 1 Aug 2025 with updates
10 Jul 2025OtherAudit exemption statement of guarantee by parent company for period ending 31/12/24
10 Jul 2025AccountsAnnual accounts made up to 31 Dec 2024
10 Jul 2025AccountsAnnual accounts filed
8 Jan 2026 Officers

Change to director Sinead Catherine Davies on 8 Jan 2026

1 Aug 2025 Confirmation Statement

Confirmation statement made on 1 Aug 2025 with updates

10 Jul 2025 Other

Audit exemption statement of guarantee by parent company for period ending 31/12/24

10 Jul 2025 Accounts

Annual accounts made up to 31 Dec 2024

10 Jul 2025 Accounts

Annual accounts filed

Recent Activity

Latest Activity

Change to director Sinead Catherine Davies on 8 Jan 2026

3 months ago on 8 Jan 2026

Confirmation statement made on 1 Aug 2025 with updates

9 months ago on 1 Aug 2025

Audit exemption statement of guarantee by parent company for period ending 31/12/24

10 months ago on 10 Jul 2025

Annual accounts made up to 31 Dec 2024

10 months ago on 10 Jul 2025

Annual accounts filed

10 months ago on 10 Jul 2025